{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T02:23:34Z","timestamp":1782786214527,"version":"3.54.5"},"reference-count":50,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2016,1,1]],"date-time":"2016-01-01T00:00:00Z","timestamp":1451606400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Fondo de Investigaci\u00f3n Sanitaria","award":["FIS 07\/0604"],"award-info":[{"award-number":["FIS 07\/0604"]}]},{"name":"Conselleria d\u2019Economia i Innovaci\u00f3","award":["CEB08\/001"],"award-info":[{"award-number":["CEB08\/001"]}]},{"DOI":"10.13039\/501100004895","name":"European Social Fund","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004895","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Human Immunology"],"published-print":{"date-parts":[[2016,1]]},"DOI":"10.1016\/j.humimm.2015.10.001","type":"journal-article","created":{"date-parts":[[2015,10,18]],"date-time":"2015-10-18T22:23:01Z","timestamp":1445206981000},"page":"20-28","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"title":["In vitro evaluation of \u03b3\u03b4 T cells regulatory function in Beh\u00e7et\u2019s disease patients and healthy controls"],"prefix":"10.1016","volume":"77","author":[{"given":"Antonio","family":"Clemente Ximenis","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catalina","family":"Cresp\u00ed Bestard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana","family":"Cambra Conejero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucio","family":"Pallar\u00e9s Ferreres","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Juan Mas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9 Luis","family":"Olea Vallejo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Rosa","family":"Juli\u00e0 Benique","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.humimm.2015.10.001_b0005","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1016\/j.autrev.2011.11.026","article-title":"New insights into the pathogenesis of Behcet\u2019s disease","volume":"11","author":"Pineton de Chambrun","year":"2012","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.humimm.2015.10.001_b0010","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1146\/annurev-immunol-032713-120216","article-title":"Gammadelta T cells: first line of defense and beyond","volume":"32","author":"Chien","year":"2014","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.humimm.2015.10.001_b0015","doi-asserted-by":"crossref","first-page":"2730","DOI":"10.4049\/jimmunol.178.5.2730","article-title":"Epigenetic and transcriptional programs lead to default IFN-gamma production by gammadelta T cells","volume":"178","author":"Chen","year":"2007","journal-title":"J. Immunol."},{"key":"10.1016\/j.humimm.2015.10.001_b0020","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1038\/nri2781","article-title":"Gammadelta T cell effector functions: a blend of innate programming and acquired plasticity","volume":"10","author":"Bonneville","year":"2010","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.humimm.2015.10.001_b0025","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1038\/nri797","article-title":"Gammadelta T cells: functional plasticity and heterogeneity","volume":"2","author":"Carding","year":"2002","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.humimm.2015.10.001_b0030","doi-asserted-by":"crossref","first-page":"704941","DOI":"10.1155\/2010\/704941","article-title":"Preferential Th1 cytokine profile of phosphoantigen-stimulated human Vgamma9Vdelta2 T cells","volume":"2010","author":"Dunne","year":"2010","journal-title":"Mediators Inflamm."},{"key":"10.1016\/j.humimm.2015.10.001_b0035","doi-asserted-by":"crossref","first-page":"4743","DOI":"10.2174\/092986709789878238","article-title":"Gammadelta T lymphocytes producing IFNgamma and IL-17 in response to Candida albicans or mycobacterial antigens: possible implications for acute and chronic inflammation","volume":"16","author":"Poggi","year":"2009","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.humimm.2015.10.001_b0040","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1111\/j.1365-3083.2009.02290.x","article-title":"Toll-like receptor expression and function in subsets of human gammadelta T lymphocytes","volume":"70","author":"Pietschmann","year":"2009","journal-title":"Scand. J. Immunol."},{"key":"10.1016\/j.humimm.2015.10.001_b0045","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1038\/cmi.2011.16","article-title":"Anti-gammadelta TCR antibody-expanded gammadelta T cells: a better choice for the adoptive immunotherapy of lymphoid malignancies","volume":"9","author":"Zhou","year":"2012","journal-title":"Cell. Mol. Immunol."},{"key":"10.1016\/j.humimm.2015.10.001_b0050","doi-asserted-by":"crossref","first-page":"e49878","DOI":"10.1371\/journal.pone.0049878","article-title":"Characterization of human gammadelta T lymphocytes infiltrating primary malignant melanomas","volume":"7","author":"Cordova","year":"2012","journal-title":"PLoS ONE"},{"key":"10.1016\/j.humimm.2015.10.001_b0055","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1182\/blood-2011-01-331298","article-title":"Differentiation, phenotype, and function of interleukin-17-producing human Vgamma9Vdelta2 T cells","volume":"118","author":"Caccamo","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.humimm.2015.10.001_b0060","doi-asserted-by":"crossref","first-page":"1764","DOI":"10.1002\/eji.200525983","article-title":"Differential requirements for antigen or homeostatic cytokines for proliferation and differentiation of human Vgamma9Vdelta2 naive, memory and effector T cell subsets","volume":"35","author":"Caccamo","year":"2005","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.humimm.2015.10.001_b0065","doi-asserted-by":"crossref","first-page":"1943","DOI":"10.1007\/s00018-013-1467-1","article-title":"Phenotype and regulation of immunosuppressive Vdelta2-expressing gammadelta T cells","volume":"71","author":"Peters","year":"2014","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.humimm.2015.10.001_b0070","doi-asserted-by":"crossref","first-page":"6693","DOI":"10.4049\/jimmunol.1002776","article-title":"Generation of human regulatory gammadelta T cells by TCRgammadelta stimulation in the presence of TGF-beta and their involvement in the pathogenesis of systemic lupus erythematosus","volume":"186","author":"Li","year":"2011","journal-title":"J. Immunol."},{"key":"10.1016\/j.humimm.2015.10.001_b0075","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1046\/j.1365-2249.1999.01069.x","article-title":"Gammadelta T cells in Behcet\u2019s disease (BD) and recurrent aphthous stomatitis (RAS)","volume":"118","author":"Freysdottir","year":"1999","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.humimm.2015.10.001_b0080","first-page":"588","article-title":"Increased peripheral blood gamma delta+ T cells and natural killer cells in Behcet\u2019s disease","volume":"19","author":"Suzuki","year":"1992","journal-title":"J. Rheumatol."},{"key":"10.1016\/j.humimm.2015.10.001_b0085","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.imlet.2010.02.005","article-title":"Phenotype markers and cytokine intracellular production by CD8+ gammadelta T lymphocytes do not support a regulatory T profile in Behcet\u2019s disease patients and healthy controls","volume":"129","author":"Clemente","year":"2010","journal-title":"Immunol. Lett."},{"key":"10.1016\/j.humimm.2015.10.001_b0090","doi-asserted-by":"crossref","first-page":"2167","DOI":"10.1084\/jem.184.6.2167","article-title":"Aerosol insulin induces regulatory CD8 gamma delta T cells that prevent murine insulin-dependent diabetes","volume":"184","author":"Harrison","year":"1996","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.humimm.2015.10.001_b0095","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1111\/j.1432-2277.2008.00669.x","article-title":"CD8+ gammadelta T regulatory cells mediate kidney allograft prolongation after oral exposure to alloantigen","volume":"21","author":"Zhou","year":"2008","journal-title":"Transpl. Int."},{"key":"10.1016\/j.humimm.2015.10.001_b0100","doi-asserted-by":"crossref","first-page":"8331","DOI":"10.4049\/jimmunol.177.12.8331","article-title":"Gammadelta T cells promote anterior chamber-associated immune deviation and immune privilege through their production of IL-10","volume":"177","author":"Ashour","year":"2006","journal-title":"J. Immunol."},{"key":"10.1016\/j.humimm.2015.10.001_b0105","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1016\/j.immuni.2007.05.020","article-title":"Tumor-infiltrating gammadelta T cells suppress T and dendritic cell function via mechanisms controlled by a unique toll-like receptor signaling pathway","volume":"27","author":"Peng","year":"2007","journal-title":"Immunity"},{"key":"10.1016\/j.humimm.2015.10.001_b0110","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1172\/JCI30989","article-title":"Small intestinal CD8+TCRgammadelta+NKG2A+ intraepithelial lymphocytes have attributes of regulatory cells in patients with celiac disease","volume":"118","author":"Bhagat","year":"2008","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.humimm.2015.10.001_b0115","doi-asserted-by":"crossref","first-page":"2403","DOI":"10.4049\/jimmunol.1202369","article-title":"Tumor-derived gammadelta regulatory T cells suppress innate and adaptive immunity through the induction of immunosenescence","volume":"190","author":"Ye","year":"2013","journal-title":"J. Immunol."},{"key":"10.1016\/j.humimm.2015.10.001_b0120","doi-asserted-by":"crossref","first-page":"834","DOI":"10.4049\/jimmunol.172.2.834","article-title":"TGF-beta 1 plays an important role in the mechanism of CD4+CD25+ regulatory T cell activity in both humans and mice","volume":"172","author":"Nakamura","year":"2004","journal-title":"J. Immunol."},{"key":"10.1016\/j.humimm.2015.10.001_b0125","first-page":"1078","article-title":"Criteria for diagnosis of Beh\u00e7et\u2019s disease","volume":"335","author":"International Study Group for Beh\u00e7et\u2019s Disease","year":"1999","journal-title":"Lancet"},{"key":"10.1016\/j.humimm.2015.10.001_b0130","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1093\/rheumatology\/38.8.728","article-title":"Behcet\u2019s disease: evaluation of a new instrument to measure clinical activity","volume":"38","author":"Bhakta","year":"1999","journal-title":"Rheumatology"},{"key":"10.1016\/j.humimm.2015.10.001_b0135","doi-asserted-by":"crossref","first-page":"2049","DOI":"10.1038\/nprot.2007.296","article-title":"Monitoring lymphocyte proliferation in vitro and in vivo with the intracellular fluorescent dye carboxyfluorescein diacetate succinimidyl ester","volume":"2","author":"Quah","year":"2007","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.humimm.2015.10.001_b0140","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.4049\/jimmunol.167.3.1245","article-title":"CD4+CD25high regulatory cells in human peripheral blood","volume":"167","author":"Baecher-Allan","year":"2001","journal-title":"J. Immunol."},{"key":"10.1016\/j.humimm.2015.10.001_b0145","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1111\/j.1365-2567.2009.03162.x","article-title":"Human peripheral gammadelta T cells possess regulatory potential","volume":"128","author":"Kuhl","year":"2009","journal-title":"Immunology"},{"key":"10.1016\/j.humimm.2015.10.001_b0150","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1097\/CJI.0b013e3181b51447","article-title":"Immune suppression by gammadelta T-cells as a potential regulatory mechanism after cancer vaccination with IL-12 secreting dendritic cells","volume":"33","author":"Traxlmayr","year":"2010","journal-title":"J. Immunother."},{"key":"10.1016\/j.humimm.2015.10.001_b0155","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1084\/jem.20021139","article-title":"Human CD25+CD4+ T suppressor cell clones produce transforming growth factor beta, but not interleukin 10, and are distinct from type 1 T regulatory cells","volume":"196","author":"Levings","year":"2002","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.humimm.2015.10.001_b0160","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1084\/jem.193.11.1295","article-title":"Human CD25+CD4+ T regulatory cells suppress naive and memory T cell proliferation and can be expanded in vitro without loss of function","volume":"193","author":"Levings","year":"2001","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.humimm.2015.10.001_b0165","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1084\/jem.193.11.1303","article-title":"Ex vivo isolation and characterization of CD4+CD25+ T cells with regulatory properties from human blood","volume":"193","author":"Dieckmann","year":"2001","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.humimm.2015.10.001_b0170","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.imlet.2009.06.005","article-title":"Identification and characterization of Foxp3+ gammadelta T cells in mouse and human","volume":"125","author":"Kang","year":"2009","journal-title":"Immunol. Lett."},{"key":"10.1016\/j.humimm.2015.10.001_b0175","doi-asserted-by":"crossref","first-page":"3574","DOI":"10.4049\/jimmunol.0901334","article-title":"Cutting edge: TGF-beta1 and IL-15 induce FOXP3+ gammadelta regulatory T cells in the presence of antigen stimulation","volume":"183","author":"Casetti","year":"2009","journal-title":"J. Immunol."},{"key":"10.1016\/j.humimm.2015.10.001_b0180","doi-asserted-by":"crossref","first-page":"1875","DOI":"10.1084\/jem.20030152","article-title":"Conversion of peripheral CD4+CD25\u2212 naive T cells to CD4+CD25+ regulatory T cells by TGF-beta induction of transcription factor Foxp3","volume":"198","author":"Chen","year":"2003","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.humimm.2015.10.001_b0185","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1002\/eji.201041270","article-title":"Gammadelta T cells develop, respond and survive \u2013 with a little help from CD27","volume":"41","author":"Born","year":"2011","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.humimm.2015.10.001_b0190","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.cellimm.2014.06.003","article-title":"Interleukin-28A promotes IFN-gamma production by peripheral blood mononuclear cells from patients with Behcet\u2019s disease","volume":"290","author":"Li","year":"2014","journal-title":"Cell. Immunol."},{"key":"10.1016\/j.humimm.2015.10.001_b0195","doi-asserted-by":"crossref","first-page":"802","DOI":"10.3109\/14397595.2013.879414","article-title":"IL-22-secreting Th22 and IFN-gamma-secreting Th17 cells in Behcet\u2019s disease","volume":"24","author":"Aktas Cetin","year":"2014","journal-title":"Mod. Rheumatol."},{"key":"10.1016\/j.humimm.2015.10.001_b0200","doi-asserted-by":"crossref","first-page":"48","DOI":"10.3109\/03009742.2012.704391","article-title":"Elevated levels of interleukin-27 and effect on production of interferon-gamma and interleukin-17 in patients with Behcet\u2019s disease","volume":"42","author":"Shen","year":"2013","journal-title":"Scand. J. Rheumatol."},{"key":"10.1016\/j.humimm.2015.10.001_b0205","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1111\/j.1365-2249.2011.04543.x","article-title":"Excessive CD4+ T cells co-expressing interleukin-17 and interferon-gamma in patients with Behcet\u2019s disease","volume":"1681","author":"Shimizu","year":"2012","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.humimm.2015.10.001_b0210","first-page":"1456","article-title":"S-antigen specific T helper type 1 response is present in Behcet\u2019s disease","volume":"14","author":"Zhao","year":"2008","journal-title":"Mol. Vis."},{"key":"10.1016\/j.humimm.2015.10.001_b0215","doi-asserted-by":"crossref","first-page":"R15","DOI":"10.1186\/ar4147","article-title":"Expression of regulatory receptors on gammadelta T cells and their cytokine production in Behcet\u2019s disease","volume":"15","author":"Parlakgul","year":"2013","journal-title":"Arthritis Res. Ther."},{"key":"10.1016\/j.humimm.2015.10.001_b0220","doi-asserted-by":"crossref","first-page":"6553","DOI":"10.4049\/jimmunol.176.11.6553","article-title":"TCR\u03b3\u03b4 intraepithelial lymphocytes are required for self-tolerance","volume":"176","author":"Locke","year":"2006","journal-title":"J. Immunol."},{"key":"10.1016\/j.humimm.2015.10.001_b0225","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1016\/j.intimp.2013.07.017","article-title":"Possible mechanisms of neutrophil activation in Behcet\u2019s disease","volume":"17","author":"Neves","year":"2013","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.humimm.2015.10.001_b0230","article-title":"Role of gamma-delta (\u03b3\u03b4) T cells in the autoimmunity","author":"Paul","year":"2014","journal-title":"J. Leukoc. Biol."},{"key":"10.1016\/j.humimm.2015.10.001_b0235","doi-asserted-by":"crossref","first-page":"3704","DOI":"10.4049\/jimmunol.1401018","article-title":"Microbe-specific unconventional T cells induce human neutrophil differentiation into antigen cross-presenting cells","volume":"193","author":"Davey","year":"2014","journal-title":"J. Immunol."},{"key":"10.1016\/j.humimm.2015.10.001_b0240","doi-asserted-by":"crossref","first-page":"4466","DOI":"10.4049\/jimmunol.178.7.4466","article-title":"Resident Vdelta1+ gammadelta T cells control early infiltration of neutrophils after Escherichia coli infection via IL-17 production","volume":"178","author":"Shibata","year":"2007","journal-title":"J. Immunol."},{"key":"10.1016\/j.humimm.2015.10.001_b0245","doi-asserted-by":"crossref","first-page":"560","DOI":"10.4049\/jimmunol.0900241","article-title":"Major role of gamma delta T cells in the generation of IL-17+ uveitogenic T cells","volume":"1831","author":"Cui","year":"2009","journal-title":"J. Immunol."},{"key":"10.1016\/j.humimm.2015.10.001_b0250","doi-asserted-by":"crossref","first-page":"5920","DOI":"10.1167\/iovs.10-6758","article-title":"Activated gammadelta T cells promote the activation of uveitogenic T cells and exacerbate EAU development","volume":"52","author":"Nian","year":"2011","journal-title":"Invest. Ophthalmol. Vis. Sci."}],"container-title":["Human Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0198885915005042?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0198885915005042?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,8,10]],"date-time":"2019-08-10T04:38:30Z","timestamp":1565411910000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0198885915005042"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,1]]},"references-count":50,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016,1]]}},"alternative-id":["S0198885915005042"],"URL":"https:\/\/doi.org\/10.1016\/j.humimm.2015.10.001","relation":{},"ISSN":["0198-8859"],"issn-type":[{"value":"0198-8859","type":"print"}],"subject":[],"published":{"date-parts":[[2016,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"In vitro evaluation of \u03b3\u03b4 T cells regulatory function in Beh\u00e7et\u2019s disease patients and healthy controls","name":"articletitle","label":"Article Title"},{"value":"Human Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.humimm.2015.10.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 American Society for Histocompatibility and Immunogenetics. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}